Soil degradation due to heavy metal accumulation under long term fertilization of paddy (Oryza sativa L.)

Long term fertility experiment (LTFE) under double rice cropping system was investigated in Tamil Nadu Rice Research Institute, Aduthurai, India with two varieties (ADT 43 and ADT 45) in two seasons (Kharif and Rabi) under six fertilizer treatments to study the heavy metal accumulation in soil and its impact on paddy. There was a significant variation in physico-chemical properties of soil due to different fertilizer treatments. The surface soil (0-15cm soil depth) in all the treatments showed relatively higher heavy metal accumulation than subsurface. In thelong run, there was a build up in the total heavy metal content in soil and it was found to be relatively high in phosphatic fertilizer applied treatments than others. Total Cd and Pb was found high, but the availability was below detectable limit indicated that Cd and Pb were found in unavailable forms, while Cu and Zn were slightly in mobile forms which had been translocated into grain and straw of paddy. The DTPA (Diphenyl Triamine Penta Aceticacid) extractable Cd and Pb in the soil was low, but there was heavy increase in Cu and Zn comparing with initial period. The rate of increase in Cd and Pb content was lower in N alone and control plots. This might be due to the long term application of phosphotic and zinc sulphate fertilizers. Cd and Pb were evenly distributed at low concentrations in grain and straw under various treatments. In case of Cu and Zn, it was relatively higher in grains and paddy strawamong various fertilizer treatments. There was no significant difference among the varietal (seasons) treatments for the accumulation of heavy metals in grain and straw

Utilization of flower waste for the removal of chromium from tannery effluent

In this work we used flower waste biomass as a biosorbent to remove Cr from tannery effluent through column experiments. The sorption capacities of biosorbent (Fine, coarse and rough grades) were also evaluated by employing chemical pretreatments viz., sodium hydroxide, acetic acid, glutaraldehyde and hydrogen peroxide. The order of percentage removal of Cr using the above pretreatments was: 10% hydrogen peroxide < Raw powdered-FWB < 2% Gluteraldehyde < 10% Acetic acid < 0.1N sodium hydroxide. Among the different grades of biosorbents used, fine grade adsorbed more Cr (70 %) than that of coarse (64%) and rough (62 %) sorbents. The removal percentage of Cr from tannery was analyzed by using Atomic Absorption Spectroscopy, the functional groups which are responsible for adsorption was examined by Fourier Transform- Infrared Spectroscopy and the amorphous behaviour of FWB facilitating metal biosorption was indicated by the X-ray diffractogram. This study showed that pretreated flower waste biomass is a potential sorbent of Cr, which could be successfully used to reduce the Cr content in tannery effluent

Soil organic carbon assessment under different land uses in Cauvery delta zone of Tamil Nadu, India

Soil organic carbon (SOC) plays a vital role in soil fertility and is important for its contributions to mitigation and adaptation to climate change. The present study was undertaken to estimate the SOC stock in soils under different land uses of Cauvery Delta zone of Tamil Nadu. Four different land uses were selected for the study viz, Forests, Agriculture, Agro-forestry and Plantations. Soil samples were collected from Madukkur and Kalathur soil series of Cauvery Delta zone for soil carbon analysis. The soil samples were fractionated into three aggregate size classes viz., macro-aggregates (250-2000µm), micro-aggregates (53-250 µm) and silt and clay sized fraction (<53 µm). At 0-30 cm depth, the forest land use stored the maximum SOC stock in the different size fractions viz. macro-sized fraction (73.0 Mg ha-1), a micro-sized fraction (76.0 Mg ha-1) and silt+clay sized fraction (77.0 Mg ha-1) in Madukkur series. Agriculture land use registered the lowest SOC stock. Among the different size fractions, silt+clay sized fraction (< 53 µm) retained the maximum SOC in all the land uses. In Kalathur series also, maximum soil organic carbon stock was recorded in forest land use. The data generated in the study will be beneficial to the user groups viz., farmers in identifying the most suitable land use for enhancing the storage of soil organic carbon thereby improving yields of crops and trees

Evaluation of localization of lead and nickel in plant cells of Amaranthus sp. and Brassica sp. absorbed from mine spoil waste

A detailed survey was undertaken in the sewage water contaminated areas of Coimbatore to select the natural hyper accumulators to rehabilitate the contaminated mine spoils. From this experiment the Pb and Ni accumulators, Amaranthus sp. and Brassica sp. were selected for further studies towards remediating the metal contaminated mine spoils. Microtomy of root, stem and leaf of Amaranthus sp. and Brassica sp. showed that the colour development in the plant species is evidence for accumulation of metals in different parts of plants and also tolerance mechanism employed by plant species under metal stress condition. The accumulation of heavy metals from soil to plant did not follow any particular pattern and varied with respect to metals, species and plant parts. However, the maximum Pb localization took place in root portion than in aerial parts. But the Ni accumulation was almost equal or higher in aerial parts (leaf and stem) compared to roots. This study revealed that the Amaranthus sp and Brassica sp stored lead and nickel in roots, leaves and stems. The roots showed more localization of metals followed by leaves and stems

Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries

Capsaicin, a pungent constituent from red chilli peppers, activates sensory nerve fibres via transient receptor potential vanilloid receptors type 1 (TRPV1) to release neuropeptides like calcitonin gene-related peptide (CGRP) and substance P. Capsaicin-sensitive nerves are widely distributed in human and porcine vasculature. In this study, we examined the mechanism of capsaicin-induced relaxations, with special emphasis on the role of CGRP, using various pharmacological tools. Segments of human and porcine proximal and distal coronary arteries, as well as cranial arteries, were mounted in organ baths. Concentration response curves to capsaicin were constructed in the absence or presence of the CGRP receptor antagonist olcegepant (BIBN4096BS, 1 μM), the neurokinin NK1 receptor antagonist L-733060 (0.5 μM), the voltage-sensitive calcium channel blocker ruthenium red (100 μM), the TRPV1 receptor antagonist capsazepine (5 μM), the nitric oxide synthetase inhibitor Nω-nitro-l-arginine methyl ester HCl (l-NAME; 100 μM), the gap junction blocker 18α-glycyrrhetinic acid (10 μM), as well as the RhoA kinase inhibitor Y-27632 (1 μM). Further, we also used the K+ channel inhibitors 4-aminopyridine (1 mM), charybdotoxin (0.5 μM) + apamin (0.1 μM) and iberiotoxin (0.5 μM) + apamin (0.1 μM). The role of the endothelium was assessed by endothelial denudation in distal coronary artery segments. In distal coronary artery segments, we also measured levels of cyclic adenosine monophosphate (cAMP) after exposure to capsaicin, and in human segments, we also assessed the amount of CGRP released in the organ bath fluid after exposure to capsaicin. Capsaicin evoked concentration-dependent relaxant responses in precontracted arteries, but none of the above-mentioned inhibitors did affect these relaxations. There was no increase in the cAMP levels after exposure to capsaicin, unlike after (exogenously administered) α-CGRP. Interestingly, there were significant increases in CGRP levels after exposure to vehicle (ethanol) as well as capsaicin, although this did not induce relaxant responses. In conclusion, the capsaicin-induced relaxations of the human and porcine distal coronary arteries are not mediated by CGRP, NK1, NO, vanilloid receptors, voltage-sensitive calcium channels, K+ channels or cAMP-mediated mechanisms. Therefore, these relaxant responses to capsaicin are likely to be attributed to a non-specific, CGRP-independent mechanism

Acute Migraine Therapy: New Drugs and New Approaches

The conceptual shift of our understanding of migraine from a vascular disorder to a brain disorder has dramatically altered the approach to the development of new medicines in the field. Current pharmacologic treatments of acute migraine consist of nonspecific and relatively specific agents. Migraine-specific drugs comprise two classes, the ergot alkaloid derivatives and the triptans, serotonin 5-HT1B/1D receptor agonists. The ergots, consisting of ergotamine and dihydroergotamine (DHE), are the oldest specific antimigraine drugs available and are considered relatively safe and effective. Ergotamine has been used less extensively because of its adverse effects; DHE is better tolerated. The triptan era, beginning in the 1990s, was a period of considerable change, although these medicines retained vasoconstrictor actions. New methods of delivering older drugs include orally inhaled DHE and the transdermal formulation of sumatriptan, both currently under study. Novel medicines being developed are targeted at neural sites of action. Serotonin 5-HT1F receptor agonists have proven effective in phase II studies and have no vascular actions. Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine. Olcegepant (BIBN4096BS) and telcagepant (MK-0974) have been shown to be safe and effective in phase I, II, and (for telcagepant) phase III clinical trials. Other targets under investigation include glutamate (AMPA/kainate), TRPV1, prostanoid EP4, and nitric oxide synthase. With new neural targets and the potential for therapeutic advances, the next era of antimigraine medications is near

Tension Type Headache in Adolescence and Childhood: Where Are We Now?

Tension type headache (TTH) is a primary headache disorder considered common in children and adolescents. It remains debatable whether TTH and migraine are separate biological entities. This review summarizes the most recent literature of TTH with regards to children and adolescents. Further studies of TTH are needed to develop a biologically based classification system that may be facilitated through understanding changes in the developing brain during childhood and adolescence

Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study

In the emergency setting, non-traumatic headache is a benign symptom in 80% of cases, but serious underlying conditions need to be ruled out. Copeptin improves risk stratification in several acute diseases. Herein, we investigated the value of copeptin to discriminate between serious secondary headache and benign headache forms in the emergency setting.; Patients presenting with acute non-traumatic headache were prospectively enrolled into an observational cohort study. Copeptin was measured upon presentation to the emergency department. Primary endpoint was serious secondary headache defined by a neurologic cause requiring immediate treatment of the underlying disease. Secondary endpoint was the combination of mortality and hospitalization within 3 months. Two board-certified neurologist blinded to copeptin levels verified the endpoints after a structured 3-month-telephone interview.; Of the 391 patients included, 75 (19%) had a serious secondary headache. Copeptin was associated with serious secondary headache (OR 2.03, 95%CI 1.52-2.70, p < 0.0001). Area under the curve (AUC) for copeptin to identify the primary endpoint was 0.70 (0.63-0.76). After adjusting for age > 50, focal-neurological abnormalities, and thunderclap onset of symptoms, copeptin remained an independent predictive factor for serious secondary headache (OR 1.74, 95%CI 1.26-2.39, p = 0.001). Moreover, copeptin improved the AUC of the multivariate logistic clinical model (p-LR-test < 0.001). Even though copeptin values were higher in patients reaching the secondary endpoint, this association was not significant in multivariate logistic regression.; Copeptin was independently associated with serious secondary headache as compared to benign headaches forms. Copeptin may be a promising novel blood biomarker that should be further validated to rule out serious secondary headache in the emergency department.; Study Registration on 08/02/2010 as NCT01174901 at clinicaltrials.gov

Current and prospective pharmacological targets in relation to antimigraine action

Migraine is a recurrent incapacitating neurovascular disorder characterized by unilateral and throbbing headaches associated with photophobia, phonophobia, nausea, and vomiting. Current specific drugs used in the acute treatment of migraine interact with vascular receptors, a fact that has raised concerns about their cardiovascular safety. In the past, α-adrenoceptor agonists (ergotamine, dihydroergotamine, isometheptene) were used. The last two decades have witnessed the advent of 5-HT1B/1D receptor agonists (sumatriptan and second-generation triptans), which have a well-established efficacy in the acute treatment of migraine. Moreover, current prophylactic treatments of migraine include 5-HT2 receptor antagonists, Ca2+ channel blockers, and β-adrenoceptor antagonists. Despite the progress in migraine research and in view of its complex etiology, this disease still remains underdiagnosed, and available therapies are underused. In this review, we have discussed pharmacological targets in migraine, with special emphasis on compounds acting on 5-HT (5-HT1-7), adrenergic (α1, α2, and β), calcitonin gene-related peptide (CGRP 1 and CGRP2), adenosine (A1, A2, and A3), glutamate (NMDA, AMPA, kainate, and metabotropic), dopamine, endothelin, and female hormone (estrogen and progesterone) receptors. In addition, we have considered some other targets, including gamma-aminobutyric acid, angiotensin, bradykinin, histamine, and ionotropic receptors, in relation to antimigraine therapy. Finally, the cardiovascular safety of current and prospective antimigraine therapies is touched upon

Concurrent Oral 1 - Therapy of rheumatic disease: OP4. Effectiveness of Rituximab in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register (BSRBR)

Background: Rituximab (RTX) in combination with methotrexate (MTX) has been licensed since 2006 for the management of severe active rheumatoid arthritis (RA) in patients who have failed at least one anti-tumour necrosis factor (anti-TNF) therapy. Published clinical trials have demonstrated the efficacy of RTX in improving both clinical symptoms and patients' physical function. This study aimed to assess the effectiveness of RTX in RA patients treated in routine clinical practice by examining clinical and patient reported outcomes six months after receiving a first course of RTX. Methods: The analysis involved 550 RA patients registered with the BSRBR, who were starting RTX and were followed up for at least 6 months. Change in Disease Activity Score (DAS28) and European League Against Rheumatism (EULAR) response were used to assess the clinical response while change in Health Assessment Questionnaire (HAQ) score was used to assess the physical function of the patients 6 months after starting RTX. The change in DAS28 and HAQ was compared between seronegative and seropositive patients and anti-TNF naïve patients versus anti-TNF failures. The response was also compared between patients receiving RTX in combination with MTX, other non-biologic disease modifying anti-rheumatic drugs (nbDMARDs) or no nbDMARDs. Results: The mean (s.d.) age of the cohort was 59 (12) years and 78% of the patients were females. The patients had a mean (s.d.) of 15 (10) years of disease duration. 16% were biologic naïve while 84% were anti-TNF failures. 32% of the patients were seronegative and 68% were seropositive. The mean (95% CI) DAS28 at baseline was 6.2 (6.1, 6.3) which decreased to 4.8 (4.7, 4.9) at 6 months of follow up. 16% were EULAR good responders, 43% were moderate responders and 41% were non responders. The mean (95% CI) change in HAQ was −0.1 (−0.2, −0.1) (Table 1). The mean change in DAS28 was similar in seropositive and seronegative patients (p = 0.18) while the anti-TNF naïve patients showed a greater reduction in DAS28 scores than anti-TNF failures (p = 0.05). Patients receiving RTX in combination with MTX showed similar changes in DAS28 and HAQ compared to patients receiving RTX alone or with other nbDMARDs. Conclusions: RTX has proven to be effective in the routine clinical practice. Anti-TNF naïve patients seem to benefit more from RTX treatment than anti-TNF failures. Disclosure statement: The authors have declared no conflicts of interes